Endocrine therapy agents used in the treatment of breast cancer include SERMs (selective estrogen receptor modulators), SERDs (selective estrogen receptor degraders), and SAIs (selective aromatase inhibitors). This evidence concerns the gene ESR1 and breast carcinoma.